A Phase I dose-escalation study of DCLL9718S, an antibody-drug conjugate targeting C-type lectin-like molecule-1 (CLL-1) in patients with acute myeloid leukemia.
Ontology highlight
SUBMITTER: Daver N
PROVIDER: S-EPMC8252033 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA